TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
Craig DJ, Crawford EL, Chen H, Grogan EL, Deppen SA, Morrison T, Antic SL, Massion PP, Willey JC. TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. BMC Cancer. 2023 Aug 23; 23(1):783.